ARQT News & Analysis

Arcutis (ARQT) EVP Masaru Matsuda sells $192k in stock

Masaru Matsuda, Executive Vice President of Arcutis Biotherapeutics (ARQT), sold $192,000 worth of stock. This transaction raises potential concerns regarding insider confidence in the company's future direction. The sale's significance relates to overall investor sentiment and market reactions to insider trading activities. Such moves can influence stock performance and investor perceptions about the company's health.